204 related articles for article (PubMed ID: 800324)
1. Immunocompetence, immunodeficiency and prognosis in cancer.
Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
[TBL] [Abstract][Full Text] [Related]
2. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
[TBL] [Abstract][Full Text] [Related]
3. Tumor immunology and immunotherapy.
Herberman RB
Laryngoscope; 1977 May; 87(5 Pt 1):722-5. PubMed ID: 321899
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.
Gross NJ; Eddie-Quartey AC
Cancer; 1976 May; 37(5):2183-93. PubMed ID: 769946
[TBL] [Abstract][Full Text] [Related]
5. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
[TBL] [Abstract][Full Text] [Related]
6. BCG and cancer.
Bast RC; Zbar B; Borsos T; Rapp HJ
N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
[No Abstract] [Full Text] [Related]
7. The use of oral BCG in the treatment or metastatic malignant melanoma.
Pritchard KI; Cowan DH; Baker MA; Osoba D; Phillips RA; Clark DA
Med Pediatr Oncol; 1976; 2(2):173-81. PubMed ID: 785199
[TBL] [Abstract][Full Text] [Related]
8. The significance of macrophages in human and experimental tumors.
Alexander P; Eccles SA; Gauci CL
Ann N Y Acad Sci; 1976; 276():124-33. PubMed ID: 800321
[No Abstract] [Full Text] [Related]
9. Feasibility study of active immunotherapy in patients with solid tumors.
Gerner RE; Moore GE
Cancer; 1976 Jul; 38(1):131-43. PubMed ID: 779950
[TBL] [Abstract][Full Text] [Related]
10. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in patients with melanoma.
Seiger HF; Shingleton WW; Metzgar RS; Buckley CE
Ann Surg; 1973 Sep; 178(3):352-9. PubMed ID: 4269702
[No Abstract] [Full Text] [Related]
12. Immunologic studies in Holstein-Friesian cattle: an immunocompetence profile.
Kateley JR; Bazzell SJ
Am J Vet Res; 1978 Oct; 39(10):1683-7. PubMed ID: 362996
[TBL] [Abstract][Full Text] [Related]
13. Immunological response in patients receiving Corynebacterium parvum therapy.
Osborn DE; Castro JE
Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
[No Abstract] [Full Text] [Related]
14. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.
Thatcher N; Swindell R; Crowther D
Clin Exp Immunol; 1979 Feb; 35(2):171-9. PubMed ID: 312169
[TBL] [Abstract][Full Text] [Related]
15. Chemoimmunotherapy of disseminated malignant melanoma with DTIC-BCG, transfer factor + melphalan.
Schwarz MA; Gutterman JU; Burgess MA; Heilbrun LK; Murphy WK; Bodey GP; Stone E; Turner-Chism V; Hersh EM
Cancer; 1980 May; 45(10):2506-15. PubMed ID: 7378986
[TBL] [Abstract][Full Text] [Related]
16. Perspectives in immunotherapy of lung cancer.
Hersh EM; Gutterman JU; Mavligit GM
Cancer Treat Rev; 1974 Mar; 1(1):65-80. PubMed ID: 4471091
[No Abstract] [Full Text] [Related]
17. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of leukemia.
Hersh EM; Gutterman JU; Mavligit GM
Med Clin North Am; 1976 Sep; 60(5):1019-42. PubMed ID: 781412
[TBL] [Abstract][Full Text] [Related]
19. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
20. Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.
Lui VK; Karpuchas J; Dent PB; McCulloch PB; Blajchman MA
Br J Cancer; 1975 Sep; 32(3):323-30. PubMed ID: 1233077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
